| scholarly article | Q13442814 |
| P50 | author | Eva K. Lee | Q75682803 |
| P2093 | author name string | Ali Pedram | |
| Ellis R Levin | |||
| Mahnaz Razandi | |||
| Albert J Evinger | |||
| P2860 | cites work | Proximal events in signaling by plasma membrane estrogen receptors | Q38361235 |
| Mechanisms of growth control in normal and malignant breast epithelium | Q38717366 | ||
| Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane | Q39740320 | ||
| Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. | Q40440497 | ||
| Lack of PTEN sequesters CHK1 and initiates genetic instability. | Q40458578 | ||
| Inhibition of Chk1 by activated PKB/Akt. | Q40563144 | ||
| Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression | Q40639757 | ||
| Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants | Q40653709 | ||
| Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells | Q43747232 | ||
| Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer | Q43864580 | ||
| Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor kappaB/CCAAT-binding transcription factor-1 complex | Q44081206 | ||
| p53 Induction: phosphorylation sites cooperate in regulating | Q44216801 | ||
| Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium | Q44457771 | ||
| Analyzing cell cycle checkpoints after ionizing radiation | Q44954201 | ||
| Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1. | Q45967119 | ||
| A conserved mechanism for steroid receptor translocation to the plasma membrane | Q46081038 | ||
| Nature of functional estrogen receptors at the plasma membrane. | Q50732202 | ||
| Cell biology: aneuploidy and cancer. | Q53336249 | ||
| Estradiol regulates tumor growth by influencing p53 and bcl-2 expression in human endometrial adenocarcinomas grown in nude mice | Q71611608 | ||
| Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells | Q78054808 | ||
| Regulation of TopBP1 oligomerization by Akt/PKB for cell survival | Q24305051 | ||
| Integration of the extranuclear and nuclear actions of estrogen | Q24533536 | ||
| Cloning of a novel receptor expressed in rat prostate and ovary | Q24607949 | ||
| Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation | Q24670580 | ||
| A transforming mutation in the pleckstrin homology domain of AKT1 in cancer | Q27646556 | ||
| DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation | Q28206029 | ||
| ATR and ATRIP: partners in checkpoint signaling | Q28207471 | ||
| Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25 | Q28247761 | ||
| Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints | Q28266170 | ||
| Cell-cycle checkpoints and cancer | Q28293996 | ||
| Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats | Q28572162 | ||
| Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators | Q28645872 | ||
| TopBP1 activates the ATR-ATRIP complex | Q29614214 | ||
| Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions | Q29614216 | ||
| DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis | Q29614217 | ||
| Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 | ||
| Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF | Q29615227 | ||
| Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc. | Q33925127 | ||
| Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function | Q33967106 | ||
| Changes in regulatory phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during normal cell cycle progression and checkpoint arrests | Q34148207 | ||
| Knockout mouse models and mammary tumorigenesis | Q34372852 | ||
| Replication checkpoint enforced by kinases Cds1 and Chk1. | Q34466698 | ||
| Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention | Q34521885 | ||
| Functional estrogen receptors in the mitochondria of breast cancer cells | Q34559531 | ||
| ErbB receptors: new insights on mechanisms and biology | Q34579265 | ||
| Site-specific phosphorylation of a checkpoint mediator protein controls its responses to different DNA structures | Q34649104 | ||
| Antibodies to estrogen receptor: Immunochemical similarity of estrophilin from various mammalian species | Q35048365 | ||
| A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer | Q35052559 | ||
| Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells | Q35147106 | ||
| Many fingers on the mitotic trigger: post-translational regulation of the Cdc25C phosphatase. | Q35601099 | ||
| Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion | Q35810732 | ||
| Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt | Q35918889 | ||
| Pure oestrogen antagonists for the treatment of advanced breast cancer | Q36586152 | ||
| Steroid receptors and their role in the biology and control of breast cancer growth | Q36673307 | ||
| Estrogen receptors outside the nucleus in breast cancer. | Q36860729 | ||
| P433 | issue | 14 | |
| P921 | main subject | estrogen | Q277954 |
| P304 | page(s) | 3374-3389 | |
| P577 | publication date | 2009-05-28 | |
| P1433 | published in | Molecular Biology of the Cell | Q2338259 |
| P1476 | title | Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair | |
| P478 | volume | 20 |
| Q37336105 | Akt switches TopBP1 function from checkpoint activation to transcriptional regulation through phosphoserine binding-mediated oligomerization |
| Q35108163 | Akt-mediated phosphorylation of XLF impairs non-homologous end-joining DNA repair |
| Q34223641 | Akt: a double-edged sword in cell proliferation and genome stability |
| Q33624839 | BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability |
| Q50146459 | Bioavailable serum estradiol may alter radiation risk of postmenopausal breast cancer: a nested case-control study. |
| Q28384992 | Bisphenol A impairs the double-strand break repair machinery in the germline and causes chromosome abnormalities |
| Q42496885 | Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein |
| Q34380520 | Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk |
| Q92702430 | Crosstalk between PTEN/PI3K/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation, Oocyte Quality and Ageing |
| Q33916912 | Cyclin D1 integrates estrogen-mediated DNA damage repair signaling |
| Q24294755 | DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors |
| Q26829155 | DNA damage response and prostate cancer: defects, regulation and therapeutic implications |
| Q36589361 | Derailed estrogen signaling and breast cancer: an authentic couple. |
| Q35120667 | Endothelin. |
| Q35975638 | Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer |
| Q33783899 | Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells |
| Q36454569 | Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells |
| Q39626579 | Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks |
| Q33646842 | Estrogen signaling and the DNA damage response in hormone dependent breast cancers |
| Q92240915 | Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression |
| Q36985168 | Exposure to bisphenol A disrupts meiotic progression during spermatogenesis in adult rats through estrogen-like activity |
| Q88777772 | Genomic-Epidemiologic Evidence That Estrogens Promote Breast Cancer Development |
| Q28297992 | High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome |
| Q44420270 | Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer |
| Q39673333 | Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. |
| Q37787578 | Hydroxyurea (therapeutics and mechanism): Metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications |
| Q28481551 | Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines |
| Q37581224 | Membrane oestrogen receptor alpha signalling to cell functions |
| Q34609967 | Minireview: Extranuclear Steroid Receptors: Roles in Modulation of Cell Functions |
| Q35922191 | Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis |
| Q36927933 | Phytoestrogen Bakuchiol Exhibits In Vitro and In Vivo Anti-breast Cancer Effects by Inducing S Phase Arrest and Apoptosis |
| Q36660250 | Plasma membrane estrogen receptors |
| Q37655166 | Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy |
| Q46878244 | Retarding the senescence of human vascular endothelial cells induced by hydrogen peroxide: effects of 17beta-estradiol (E2) mediated mitochondria protection |
| Q34193741 | Role of AKT signaling in DNA repair and clinical response to cancer therapy |
| Q36592296 | Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways |
| Q99571998 | The membrane-associated form of cyclin D1 enhances cellular invasion |
| Q34404780 | The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas |
| Q90357642 | Tissue specificity of DNA damage response and tumorigenesis |
| Q33692847 | Translating extranuclear steroid receptor signaling to clinical medicine |
| Q41932983 | Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling |
Search more.